KD Logo

A company insider recently bought 1,200,000 shares of DiaMedica Therapeutics Inc [DMAC]. Should You Buy?

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. DiaMedica Therapeutics Inc shares valued at $3,000,000 were purchased by Von Koch Thomas on Jun 28 ’24. At $2.50 per share, Von Koch Thomas acquired 1,200,000 shares. The insider’s holdings grew to 5,526,435 shares worth approximately $23.1 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Also, STAHLBERG JAN purchased 1,200,000 shares, netting a total of over 3,000,000 in proceeds. Following the buying of shares at $2.50 each, the insider now holds 5,221,608 shares.

As published in their initiating research note from H.C. Wainwright on October 07, 2024, DiaMedica Therapeutics Inc [DMAC] has been a Buy and the price target has been revised to $7. As of June 22, 2023, Oppenheimer has increased its “Perform” rating to a “an Outperform” for DMAC. Earlier on April 09, 2021, Oppenheimer initiated its rating. Their recommendation was “an Outperform” for DMAC stock.

Analyzing DMAC Stock Performance

During the last five days, there has been a surge of approximately 1.46%. Over the course of the year, DiaMedica Therapeutics Inc shares have jumped approximately 47.18%. Shares of the company reached a 52-week high of $4.95 on 09/13/24 and a 52-week low of $2.14 on 06/24/24. A 50-day SMA is recorded $4.29, while a 200-day SMA reached $3.38. Nevertheless, trading volume fell to 1.08 million shares from 40700.0 shares the previous day.

Support And Resistance Levels for DiaMedica Therapeutics Inc (DMAC)

According to the 24-hour chart, there is a support level at 4.03, which, if violated, would cause prices to drop to 3.88. In the upper region, resistance lies at 4.33. The next price resistance is at 4.48. RSI (Relative Strength Index) is 48.23 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.13, which suggests the price will decrease in the coming days. Percent R is at 50.00%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.

Most Popular